Status:
UNKNOWN
Prognostic Factors of COVID19
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
SARS-CoV-2
Eligibility:
All Genders
1+ years
Brief Summary
COVID-19 is an emerging disease, for which no specific treatment options are currently available. Since the end of February 2020, and due to a SARS-CoV-2 superspreading event (religious meeting), the ...
Eligibility Criteria
Inclusion
- Adult and pediatric with suspicion or a confirmed SARS-CoV-2 infection
- Patient who has signed a non-opposition form (or a form signed by a family member or a support person if the seriousness of the patient's condition and the emergency situation do not allow it) or who has given his oral agreement to the doctor
Exclusion
- Patient's explicit refusal to participate
- Subject deprived of liberty or subject to the protection of justice
- Subject under guardianship or trusteeship
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04405726
Start Date
March 27 2020
End Date
March 1 2022
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Virologie - Hôpital Civil
Strasbourg, France, 67091